Exchange: NASDAQ·Updated 07:59 PM EST

BPTHBio-Path Holdings Inc

$0.21
$0.4232
(66.83%)
Today
Closed $0.21
$0.0042
(2.00%)
After Hours
Reported EarningsMay 15
Mkt Cap$2.36M
Vol6.93M
News
all
press releases
News Placeholder
Bio-Path Rockets To 4-Month High As Obesity Drug Shows Promise For Diabetes: Retail In Celebration Mode
The company said it has initiated animal studies to further confirm the drug’s efficacy, with plans to launch a first-in-human Phase 1 trial in 2025.
Stocktwits
<
...
1
>

Advertisement|Remove ads.